Innovative treatment method offers hope for treating wet AMD

Age-related macular (AMD) degeneration is a leading cause of vision impairment and blindness in the elderly population.

AI tool enhances cancer diagnosis by transforming standard tissue images

VirtualMultiplexer transforms histology images into detailed cancer markers, streamlining diagnostics and enhancing patient outcomes through AI innovation.

September 12, 2024

How Biocon Biologics is taking on the US biosimilars market

Biocon Biologics is betting big that it can be a top US biosimilars company. With its $3 billion acquisition of Viatris’ biosimilar portfolio last November

September 7, 2023

Gilead, Tentarix partner on cancer and inflammation therapies

The partnerships aim to develop multifunctional, conditional protein therapeutics for oncology and inflammatory diseases. Credit: Kateryna Kon/Shutterstock.com. Gilead Sciences has entered into three multi-year partnerships

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.